Fundraising Fox
TRACON Pharmaceuticals
San Diego, US · Delaware corporation · 11 employees on LinkedIn · 2 known investors
Find your way into TRACON Pharmaceuticals
Sign up to see every warm intro you have to TRACON Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TRACON Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TRACON Pharmaceuticals was a biopharmaceutical company that is currently undergoing liquidation and dissolution as of November 2024.
Founders & leadership
HC
H CASEY LOGANChief Business Officer2013–2018Executive officer at TRACON Pharmaceuticals with 25 years of experience in pharmaceutical business development, strategic planning, and M&A activities.
PL
PATRICIA L. BITARExecutive
Board
PW
SW
STEPHEN WORLANDBoard director
WL
WILLIAM LARUEBoard director
JR
J. RAINER TWIFORDBoard director
MM
MARTIN MATTINGLYBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$39.7M disclosed across 2 rounds · 2017–2018
▶$38.7MraisedApr 2018 · 11 investors · BiotechnologyRule 506(b)
▶$38.7MraisedApr 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J. RAINER TWIFORDDirector
- PAUL WALKERDirector
- TED WANGDirector
- WILLIAM LARUEDirector
- CHARLES P. THEUERExecutive Officer, Director
- PATRICIA L. BITARExecutive Officer
- STEPHEN WORLANDDirector
- MARTIN MATTINGLYDirector
- Offering amount
- $75.7M
- Amount sold
- $38.7M
- Sales commissions
- $2M
- Placement agents
- Angel Pond Capital LLC, LifeSci Capital
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedMay 2017 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedMay 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN WORLANDDirector
- WILLIAM LARUEDirector
- J. RAINER TWIFORDDirector
- H CASEY LOGANExecutive Officer
- CHARLES P. THEUERExecutive Officer, Director
- PATRICIA L. BITARExecutive Officer
- MARTIN MATTINGLYDirector
- PAUL WALKERDirector
- Offering amount
- $21M
- Amount sold
- $1M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does TRACON Pharmaceuticals do?
- TRACON Pharmaceuticals was a biopharmaceutical company that is currently undergoing liquidation and dissolution as of November 2024.
- Who are TRACON Pharmaceuticals's investors?
- TRACON Pharmaceuticals's investors include New Enterprise Associates (NEA), Runway Growth Capital.
- How much funding has TRACON Pharmaceuticals raised?
- TRACON Pharmaceuticals has disclosed $39.7M raised across 2 rounds.
- Where is TRACON Pharmaceuticals headquartered?
- TRACON Pharmaceuticals is headquartered in San Diego, US.